The aim of this study is to test the efficacy of the study drug on the occurrence of cardiac events. This study will last approximately 5 years with visits every other month, some of which are phone visits. This study will include blood draws, physical exams, vital signs, urine collection, EKGs and study drug dispensing. All study related testing will be completed at no cost to the patient. Compensation may occur for qualified patients.
- Patient Population – Patients with a recent history of acute coronary syndrome.
- Sponsor – Sanofi; Regeneron
- Contact Information – (402) 384 – 2705, MPCHeartConsultantsResearch@nmhs.org
- View this study on ClinicalTrials.gov
This Study Is Closed To Enrollment.